Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: rhEPO;   Drug: Placebo;   Drug: Iron therapy
Sponsor:   GlaxoSmithKline
Not yet recruiting - verified August 2016

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: Darbepoetin alfa;   Drug: Placebo;   Drug: Iron Therapy
Sponsor:   GlaxoSmithKline
Not yet recruiting - verified August 2016

Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease

Conditions:   Venous Thromboembolism;   Venous Thrombosis;   Pulmonary Embolism
Intervention:  
Sponsors:   Registro Mexicano Multidisciplinario De Pacientes Con Enfermedad Tromboembolica Venosa;   Bayer;   Webmedica
Not yet recruiting - verified August 2016

Steps to Eliminate Postoperative Problems

Condition:   Bladder Cancer
Intervention:   Other: Financial Incentive to Increase Ambulation
Sponsors:   University of Pennsylvania;   Children's Hospital of Philadelphia;   National Center for Advancing Translational Science (NCATS)
Not yet recruiting - verified August 2016

Tranexamic Acid in Revision Total Joint Arthroplasty

Conditions:   Revision Total Knee Arthroplasty;   Revision Total Hip Arthroplasty;   Acute Blood Loss Anemia
Interventions:   Procedure: Revision Total Knee Arthroplasty (TKA);   Procedure: Revision Total Hip Arthroplasty (THA)
Sponsors:   Rush University Medical Center;   Mayo Clinic
Recruiting - verified August 2016

IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Intervention:   Biological: Blood sampling
Sponsor:   Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified August 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Conditions:   Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions:   Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
Recruiting - verified August 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified August 2016

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:  
Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified August 2016

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial

Conditions:   Renal Cell Carcinoma;   Kidney Cancer
Interventions:   Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
Sponsors:   Consorzio Oncotech;   Clinical Research Technology S.r.l.;   Quercegen Pharmaceuticals
Not yet recruiting - verified June 2016

Osteopathic Treatment and Deep Vein Thrombosis (DVT)

Condition:   Deep Vein Thrombosis (DVT)
Intervention:   Other: Osteopathic Treatment
Sponsor:   Nova Scotia Health Authority
Recruiting - verified August 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified August 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified August 2016

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic Endovascular System

Conditions:   Deep Vein Thrombosis;   Post-thrombotic Syndrome
Intervention:   Device: EkoSonic Endovascular System
Sponsors:   EKOS Corporation;   BTG International Inc.
Recruiting - verified August 2016

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2016

Compression in Anklefracture Treatment, The CAT-study

Condition:   Ankle Fractures
Interventions:   Device: Flowtron Hydroven and Coban2 Lite;   Other: Braun frame;   Device: compression bandage
Sponsors:   Hillerod Hospital, Denmark;   The Research Unit, Northzealand Hospital;   Department of Orthopedic Surgery, Northzealand Hospital
Active, not recruiting - verified August 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified August 2016

Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis

Condition:   Thrombosis
Intervention:   Other: No intervention
Sponsor:   University Hospital, Basel, Switzerland
Suspended - verified August 2016